Roberta D. Rodriguez

Dr. Roberta D. Rodriguez


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2017 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
CSClaudia K. Suemoto
Claudia K. Suemoto
RFRenata E. L. Ferretti-Rebustini
Renata E. L. Ferretti-Rebustini
RRRoberta D. Rodriguez
Roberta D. Rodriguez
RLRenata E. P. Leite
Renata E. P. Leite
LSLuciana Soterio
Luciana Soterio
LGLea T. Grinberg
Lea T. Grinberg
Clinicopathological studies are important in determining the brain lesions underlying dementia. Although almost 60% of individuals with dementia live in developing countries, few clinicopathological studies focus on these individuals. We investigated the frequency of neurodegenerative and vascular-related neuropathological lesions in 1,092 Brazilian admixed older adults, their correlation with cognitive and neuropsychiatric symptoms, and the accuracy of dementia subtype diagnosis. In this cross-sectional study, we describe clinical and neuropathological variables related to cognitive impairment in 1,092 participants (mean age = 74 y, 49% male, 69% white, and mean education = 4 y). Cognitive function was investigated using the Clinical Dementia Rating (CDR) and the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE); neuropsychiatric symptoms were evaluated using the Neuropsychiatric Inventory (NPI). Associations between neuropathological lesions and cognitive impairment were investigated using ordinal logistic regression. We developed a neuropathological comorbidity (NPC) score and compared it to CDR, IQCODE, and NPI scores. We also described and compared the frequency of neuropathological diagnosis to clinical diagnosis of dementia subtype. Forty-four percent of the sample met criteria for neuropathological diagnosis. Among these participants, 50% had neuropathological diagnoses of Alzheimer disease (AD), and 35% of vascular dementia (VaD). Neurofibrillary tangles (NFTs), hippocampal sclerosis, lacunar infarcts, hyaline atherosclerosis, siderocalcinosis, and Lewy body disease were independently associated with cognitive impairment. Higher NPC scores were associated with worse scores in the CDR sum of boxes (β = 1.33, 95% CI 1.20–1.46), IQCODE (β = 0.14, 95% CI 0.13–0.16), and NPI (β = 1.74, 95% CI = 1.33–2.16). Compared to neuropathological diagnoses, clinical diagnosis had high sensitivity to AD and high specificity to dementia with Lewy body/Parkinson dementia. The major limitation of our study is the lack of clinical follow-up of participants during life. NFT deposition, vascular lesions, and high NPC scorewere associated with cognitive impairment in a unique Brazilian sample with low education. Our results confirm the high prevalence of neuropathological diagnosis in older adults and the mismatch between clinical and neuropathological diagnoses.

12 March 2019 in Brain Pathology
Verified
Journal Article
Open access
PDF file
CSClaudia Suemoto
Claudia Suemoto
RLRenata E.P. Leite
Renata E.P. Leite
RFRenata Eloah de Lucena Ferretti-Rebustini
Renata Eloah de Lucena Ferretti-Rebustini
RRRoberta D. Rodriguez
Roberta D. Rodriguez
RNRicardo Nitrini
Ricardo Nitrini
LGLea T. Grinberg
Lea T. Grinberg
Objective: To compare neuropathological correlates of cognitive impairment between very old and younger individuals from a Brazilian clinicopathological study.Methods: We assessed the frequency of neuropathological lesions and their association with cognitive impairment (Clinical Dementia Rating scale ≥0.5) in the 80 or over age group compared to younger participants, using logistic regression models adjusted for sex, race and education.Results: Except for infarcts and siderocalcinosis, all neuropathological lesions were more common in the 80 or over age group (n = 412) compared to 50–79 year olds (n = 677). Very old participants had more than twice the likelihood of having ≥2 neuropathological diagnoses than younger participants (OR = 2.66, 95% CI = 2.03–3.50). Neurofibrillary tangles, infarcts and hyaline arteriolosclerosis were associated with cognitive impairment in the two age groups. Siderocalcinosis was associated with cognitive impairment in the younger participants only, while Lewy body disease was associated with cognitive impairment in the very old only. In addition, we found that the association of infarcts and multiple pathologies with cognitive impairment was attenuated in very old adults (Infarcts: P for interaction = 0.04; and multiple pathologies: P = 0.05). However, the predictive value for the aggregate model with all neuropathological lesions showed similar discrimination in both age groups [Area under Receiver Operating Characteristic curve (AUROC) = 0.778 in younger participants and AUROC = 0.765 in the very old].Conclusion and relevance: Despite a higher frequency of neuropathological findings in the very old group, as found in studies with high‐income populations, we found attenuation of the effect of infarcts rather than neurofibrillary tangles and plaques as reported previously.

19 October 2021 in Neurology
Verified
Journal Article
Closed access
PDF file
HCHsin Fen Chien
Hsin Fen Chien
RRRoberta D. Rodriguez
Roberta D. Rodriguez
VBVincenzo Bonifati
Vincenzo Bonifati
RNRicardo Nitrini
Ricardo Nitrini
CPCarlos Augusto Pasqualucci
Carlos Augusto Pasqualucci
EBEgberto Reis Barbosa
Egberto Reis Barbosa
Objective: To describe the postmortem neuropathological findings of a patient with Kufor Rakeb Syndrome (KRS) due to ATP13A2 mutation. KRS is characterized by juvenile-onset, levodopa-responsive parkinsonism associated with pyramidal signs, supranuclear gaze palsy, and cognitive impairment. Methods: Detailed neuropathological analysis of the brain. The patient had a genetically confirmed ATP13A2 homozygous missense mutation and died at age 38, 26 years after the onset of his symptoms. Results: The main brain neuropathological findings were widespread neuronal and glial lipofuscin accumulation with no Lewy-body type inclusions and absence of 𝛼-synuclein-, tau-, 𝛽-amyloid-, and TDP-43-protein-positive pathologies. Sparse iron deposits were observed in several brain areas but no obvious axonal spheroids were identified. Discussion: This is to our knowledge the first KRS postmortem neuropathological description. Iron deposits were found but were not associated with increased axonal spheroids, as frequently observed in neurodegeneration with brain iron accumulation (NBIA). ATP13A2 mutations have been described in patients with neuronal ceroid lipofuscinosis (CLN). Moreover animal models with these mutations develop neurodegenerative disorders with CLN pathology. Therefore, our findings support that ATP13A2 mutations may be considered a genetic etiology of neuronal lipofuscinosis.

12 August 2022 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
JPJacy Bezerra Parmera
Jacy Bezerra Parmera
MOMarcos Castello Barbosa de Oliveira
Marcos Castello Barbosa de Oliveira
RRRoberta D. Rodriguez
Roberta D. Rodriguez
ACArtur Paiva Coutinho
Artur Paiva Coutinho
Background: Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic adult-onset primary tauopathies clinically classified among the atypical parkinsonian syndromes. They are intrinsically related with regard to their clinical features, pathology, biochemistry, and genetic risk factors. Objectives: This review highlights the current knowledge on PSP and CBD, focusing on evolving clinical concepts, new diagnostic criteria, and advances in biomarkers. Methods: We performed a non-systematic literature review through the PubMed database. The search was restricted to articles written in English, published from 1964 to date. Results: Clinicopathologic and in vivo biomarkers studies have broadened PSP and CBD clinical phenotypes. They are now recognized as a range of motor and behavioral syndromes associated with underlying 4R-tauopathy neuropathology. The Movement Disorders Society PSP diagnostic criteria included clinical variants apart from the classical description, increasing diagnostic sensitivity. Meanwhile, imaging biomarkers have explored the complexity of symptoms and pathological processes related to corticobasal syndrome and CBD. Conclusions: In recent years, several prospective or clinicopathologic studies have assessed clinical, radiological, and fluid biomarkers that have helped us gain a better understanding of the complexity of the 4R-tauopathies, mainly PSP and CBD.

5 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
KLKun Leng
Kun Leng
ELEmmy Li
Emmy Li
RERana Eser
Rana Eser
APAntonia Piergies
Antonia Piergies
RSRene Sit
Rene Sit
MKMartin Kampmann
Martin Kampmann
Alzheimer’s disease (AD) is characterized by the selective vulnerability of specific neuronal populations, the molecular signatures of which are largely unknown. To identify and characterize selectively vulnerable neuronal populations, we used single-nucleus RNA sequencing to profile the caudal entorhinal cortex and the superior frontal gyrus – brain regions where neurofibrillary inclusions and neuronal loss occur early and late in AD, respectively – from postmortem brains spanning the progression of AD-type tau neurofibrillary pathology. We identified RORB as a marker of selectively vulnerable excitatory neurons in the entorhinal cortex, and subsequently validated their depletion and selective susceptibility to neurofibrillary inclusions during disease progression using quantitative neuropathological methods. We also discovered an astrocyte subpopulation, likely representing reactive astrocytes, characterized by decreased expression of genes involved in homeostatic functions. Our characterization of selectively vulnerable neurons in AD paves the way for future mechanistic studies of selective vulnerability and potential therapeutic strategies for enhancing neuronal resilience.

4 February 2022 in medRxiv
Verified
Preprint
Open access
PDF file
MNMichel Satya Naslavsky
Michel Satya Naslavsky
CSClaudia Suemoto
Claudia Suemoto
LBLuciano Abreu Brito
Luciano Abreu Brito
MSMarília Oliveira Scliar
Marília Oliveira Scliar
RFRenata Eloah de Lucena Ferretti-Rebustini
Renata Eloah de Lucena Ferretti-Rebustini
LGLea T. Grinberg
Lea T. Grinberg
Dementia is more prevalent in Blacks than in Whites, likely due to a combination of environmental and biological factors. Paradoxically, clinical studies suggest an attenuation of APOE ε4 risk of dementia in African ancestry (AFR), but lack of neuropathological data preclude the interpretation of the biological factors underlying these findings, including the association between APOE ε4 risk and Alzheimer’s disease (AD) pathology, the most frequent cause of dementia. We investigated the interaction between African ancestry, AD-related neuropathology, APOE genotype , and functional cognition in a postmortem sample of 400 individuals with a range of AD pathology severity and lack of comorbid neuropathology from a cohort of community-dwelling, admixed Brazilians. Increasing proportions of African ancestry (AFR) correlated with a lower burden of neuritic plaques (NP). However, for individuals with high levels of NP and neurofibrillary tangles (NFT), AFR proportion was associated with worse Clinical Dementia Rating sum of boxes (CDR-SOB). Among APOE ε4 carriers, the association between AFR proportion and CDR-SOB disappeared. APOE local ancestry inference of a subset of 309 individuals revealed that, in APOE ε4 noncarriers, non-European APOE background associated with lower NP burden, but with worst cognitive outcomes compared to European APOE when adjusting by the similar NP burden. Finally, APOE ε4 was associated with worse AD neuropathological burden only in a European APOE background. APOE genotype and its association with AD neuropathology and clinical pattern are highly influenced by ancestry, with AFR associated with lower NP burden and attenuated APOE4 risk compared to European ancestry.